National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.
about
Outcomes from unrelated donor hematopoietic stem cell transplantationT Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical OutcomeEffect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysisClinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysisSupport of unrelated stem cell donor searches by donor center-initiated HLA typing of potentially matching donors.High-resolution typing for unrelated donor transplantation: how far do we go?Pathogenesis and management of graft-versus-host disease.HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk categoryThe Impact of HLA-C Matching on Donor Identification Rates in a European-Caucasian Population.Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis.The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children.Hematopoietic stem cell transplantation in children with leukemia: a single institution experience with respect to donors.Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match.Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantation.A perspective on the selection of unrelated donors and cord blood units for transplantationEffect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCTEvaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.The Role of HLA in Cord Blood Transplantation.Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept studySimulation shows that HLA-matched stem cell donors can remain unidentified in donor searches.Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application.Donor registries and search strategiesGenetics of graft-versus-host disease: the major histocompatibility complex.Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemiaDissecting graft-versus-leukemia from graft-versus-host-disease using novel strategiesMultiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.Complete donor chimerism is a prerequisite for the effect of Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) on acute graft-versus-host disease.HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States.A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units.Validation of the EBMT Risk Score for South Brazilian Patients Submitted to Allogeneic Hematopoietic Stem Cell Transplantation.Toward an optimal global stem cell donor recruitment strategy.Concise review: parthenote stem cells for regenerative medicine: genetic, epigenetic, and developmental featuresBSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.An integrated tool to study MHC region: accurate SNV detection and HLA genes typing in human MHC region using targeted high-throughput sequencing.Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French-Swiss retrospective study.Matching inside and outside the HLA molecule in allogeneic hematopoietic stem cell transplantation.Superior transplantation outcomes of 8/8-matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission.Improved survival in matched unrelated donor transplant for childhood ALL since the introduction of high-resolution matching at HLA class I and II.Accuracy of SNPs to predict risk of HLA alleles associated with drug-induced hypersensitivity events across racial groups.Identification of a novel HLA-DRB1*04:94N allele by polymerase chain reaction sequence-based typing.
P2860
Q27027854-D152AD4B-E936-41D0-9280-40AF258CA506Q28072227-A689B6F1-5338-4947-AE7A-A839D000F64DQ30424777-223F9DA8-16BD-4436-90FD-6D6F49D18D33Q33689153-24306C5F-E515-4856-B137-6AA10823B382Q33916233-F1C0B875-967F-48E9-89F9-9A89DAFE2767Q33999087-DB9F1888-EB5B-4130-AC38-03B78E7F602DQ34077479-0531E437-C2C8-4FC4-890A-CF70AB93BAEEQ34107708-E5E1CC88-8DAD-4BE0-A76B-60569D595C16Q34342032-08D9C40C-DC79-4A8E-9FB4-079B7859589CQ34579653-CD3CA37F-8513-430E-813C-00EE5128D669Q34729272-91DDAE87-8D6E-4EDD-AF74-CDDB071BC4A5Q35590604-1A728E6B-CCCC-4E5D-9EA9-F481A4DEE23EQ35871172-C6279EEB-12E2-4FCD-8E63-29D3692B0644Q36019981-B1F4696D-FD96-4F27-A025-94335004B9C1Q36100445-F6D98D76-17FA-412A-BF5D-A4B0CCBFDF5EQ36305321-835C9DCC-2576-4EC1-951D-90692CCBF592Q36305355-4257D042-1ECC-4A25-86D3-CF26043FB424Q36336608-6BBC6D31-D351-4C02-BE55-AA5B68986133Q36545617-0AE606C6-8377-4659-9A17-3BA9222B64FEQ36579389-AA5CC65B-B933-45FD-801D-A01BC455A95DQ36605814-0B1AFFF1-1565-4583-8A46-F134E52168FBQ36728745-860F3FBF-83F6-472A-91C8-A3FE2BE30E42Q36766250-73EB6E73-F8C2-4D7B-84B6-DF128C598CAEQ36805898-12841AE5-1BF9-40E1-9FCF-F2D3CF3B66BBQ36819337-31A4BDD2-CED0-484B-A67A-08225A4DC0FEQ36889775-2CC5C4F7-FC00-4726-8AA2-01FDB6F6CD4DQ37337095-6356CDFB-B090-43E7-9D51-5C7F17CEBC5FQ37354960-9363A949-52BB-47C6-BAA8-62E221CCFEE3Q37384843-FA8D5EBE-3979-4F3B-AC56-D4442822CBDDQ37422385-BDB5F03C-350E-4C38-B7E4-3823FABEF076Q37534059-32AAB39B-567D-4FE3-B450-831D52664ED6Q37635469-7BC90387-CEE5-4F37-802D-9F826059DEB2Q38922475-03C3E9A6-FC30-4940-B974-ACABC191810EQ40127472-F48DDF47-BD44-4D92-A2E3-FBE0CB738FBEQ40766354-912B185B-4698-46C0-BA7E-AA0071F6B627Q42388548-F9D12EB3-5463-4B9B-98F5-81BEE7A6E8B5Q43671073-5F35E45C-5562-432B-9875-3168967A2681Q43989922-671F9335-5FB2-4398-AC13-3817AFD78A07Q44858073-F41CCDBA-F87D-4D50-B200-FDE65191AEC5Q45326922-ED0882D6-0E8F-4536-9085-7B37507E3466
P2860
National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
National marrow donor program ...... ematopoietic cell transplants.
@en
National marrow donor program ...... ematopoietic cell transplants.
@nl
type
label
National marrow donor program ...... ematopoietic cell transplants.
@en
National marrow donor program ...... ematopoietic cell transplants.
@nl
prefLabel
National marrow donor program ...... ematopoietic cell transplants.
@en
National marrow donor program ...... ematopoietic cell transplants.
@nl
P2093
P1476
National marrow donor program ...... ematopoietic cell transplants.
@en
P2093
Ann Woolfrey
Carlheinz Müller
Carolyn K Hurley
Dennis L Confer
Michelle Setterholm
Naynesh R Kamani
Robert A Bray
Stephen Spellman
P356
10.1016/J.BBMT.2008.06.014
P433
P577
2008-09-01T00:00:00Z